Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases
Hypoxia-inducible factors – regulation, role and comparative aspects in tumourigenesis
CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma
Breed differences in the proportional morbidity of testicular tumours and distribution of histopathologic types in a population-based canine cancer registry
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma
Characterization of β -catenin expression in canine osteosarcoma
Identification of cancer stem cells in canine glioma and resistance to therapeutic modalities
Characterizing the innate immune and potential anticancer effects of TLR7 agonism in normal balb/c mice
Evaluation of the receptor tyrosine kinase inhibitor, masitinib mesylate, in canine haemangiosarcoma cell lines
Breed-associated differential microRNA expression in canine osteosarcoma
Isolation and characterization of tumour-initiating cells in two canine melanoma cell lines
The effect of radiation on VEGF and VEGFR expression in the caninemelanoma cell line TLM 1
Blunted immune response in dogs with neoplasia
Phase II trial of vinblastine in dogs with transitional cell carcinoma
Phase II clinical trial of metronomic chlorambucil in dogs with transitional cell carcinoma of the urinary bladder
Safety evaluation of combination of vinblastine and toceranib phosphate (Palladia®) in dogs withmast cell tumours (MCT): a phase I dose-finding study
Hypofractionated radiation therapy plus toceranib for unresectable caninemast cell tumours
Stereotactic radiation therapy for the treatment of canine nasal tumours
Phase I study of a simultaneous integrated boost using helical tomotherapy for canine sinonasal tumours: preliminary results
Survival of dogs treated with various radiation protocols for intranasal sarcomas
Osteosarcoma of the canine head: a retrospective analysis of 136 cases (1991–2008)
Evaluation of ifosfamide rescue therapy for metastatic canine osteosarcoma
Efficacy of doxorubicin for histiocytic sarcoma in dogs
Carboplatin sustained-release delivery system for the treatment of cancer in dogs: a phase I/II prospective, dose escalation, multi-institutional study
Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer
Intravenous administration of docetaxel in cats is safe and allows greater dose intensity than oral delivery
Clinical characteristics and outcome after splenectomy in dogs with splenicmarginal zone lymphoma
Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma
Immunohistochemical characterization of canine indolent lymphoma
Histological and immunohistochemical characterization of thymic epithelial tumours in the dog
Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer
Chemotherapy followed by abdominal cavity irradiation for feline lymphoblastic lymphoma
Evidence for biological activity of Palladia in thyroid carcinoma and osteosarcoma
Biological activity of toceranib (Palladia) in canine anal gland anal SAC adenocarcinoma (AGASACA)
Biological activity and adverse event profile in cats treated with toceranib phosphate
First-line and rescue therapy withmasitinib integrated protocols for canine cutaneousmast cell tumours
T-cell therapy for out-bred canines with spontaneous B-cell non-Hodgkin lymphoma
Canine lingual lymphoma: a retrospective review of eight cases (2000–2010)
Use ofmitoxantrone, carboplatin, cytosine arabinoside and prednisone (MiCAP) for the treatment of refractory canine lymphoma
Update: autologous peripheral blood stem cell transplantation for the treatment of canine B-cell lymphoma
Comparison of two chemotherapy protocols as first rescue in canine lymphoma
Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for feline lymphoma
PalladiaTM year 1 clinical experience: online case entry summary
Feline colonic adenocarcinoma treated with subtotal colectomies and adjuvant carboplatin - 18 cases
A tolerability trial of metronomic lomustine in dogs with cancer
Prospective randomized clinical trial assessing the efficacy of Denamarin® for the prevention of CCNU-induced hepatopathy in tumour-bearing dogs
Outcome following simultaneous bilateral thyroidectomy for the treatment of thyroid carcinoma in 15 dogs
A retrospective study of canine thyroid carcinoma: evaluation of the significance of histological subtype and other factors on prognosis
Retrospective study of 21 dogs with parathyroid carcinoma treated with surgical excision
Prognostic and predictive values of heat shock proteins in canine osteosarcoma
Gene expression analysis in canine osteosarcoma: axial versus appendicular
Characterizing beta-catenin expression in canine osteosarcoma
Biological effect of tyrosine kinase inhibitors on three canine mast cell tumour cell lines with and without c-kitmutation
In vitro evaluation of the non-steroidal anti-inflammatory drug, tolfenamic acid, for canine solid tumours
Canine splenicmasses - is size predictive of malignancy?
Intentionalmarginal excision of canine limb soft tissue sarcomas followed by radiotherapy
A retrospective analysis of survival times in dogs undergoing palliative radiation therapy for appendicular osteosarcoma: 70 cases (1989–2009)
Ulnar osteosarcoma in dogs: 30 cases (1992–2008)
Interim analysis of randomized placebo-controlled clinical trial of radiation therapy +/− pamidronate for palliative treatment of canine appendicular osteosarcoma
Characterization of 18F-deoxyglucose uptake of canine osteosarcomas with PET-CT imaging
Peri-articular histiocytic sarcoma and synovial cell sarcoma in BerneseMountain dogs: a retrospective investigation of the prevalence of these tumours in association with previously diseased joints
Epidemiology and natural behaviour of primary lung cancer in dogs: database query and retrospective evaluation of 344 cases
A retrospective analysis of prostatic carcinoma in the dog: 66 cases (1990–2010)
Evaluation of NHS-IL12-IL2 and NHS-IL12 fusion proteins in tumour-bearing dogs
Long-term survival in caninemalignant melanoma after adenovector CD40 ligand immunotherapy
Thermochemotherapy for the treatment of equine solid tumours
CyberKnife radiosurgery for irradiation of tumours in dogs and cats
Metronomic cyclophosphamide increases the expression of TH17 cells and favours the development of a pro-inflammatory immune response in mice with soft tissue sarcoma
Masitinib decreases cell proliferation, promotes apoptosis and inhibits PDGF-induced phosphorylation of PDGF receptor in vaccine-associated sarcoma cells
BRCA1, BRCA2 and DLA class II are associated with canine mammary tumour development
Sensitivity test in vitro to metformin on cancer stem cells of felinemammary carcinoma
Indirect measurement of dihydropyrimidine dehydrogenase activity in dogs
Investigating the mTOR pathway in caninemalignant histiocytic tumours
Identification of JAK2mutation in a canine primary polycythaemia
Expression of high-mobility group B1 (HMGB1) and receptor for advanced glycation endproducts (RAGE) in caninemalignant histiocytosis
Multiphotonmicroscopy as a diagnostic tool for lung cancer: ex vivo imaging ofmurine and canine lung neoplasms
Antitumour effects of canine adipose tissue-derived mesenchymal stem-cell-based IFN-β gene therapy and cisplatin in amouse melanoma model
Array-based definition of the CpG-island DNA methylation of canine chronic lymphocytic leukaemia